Funding news
ProFuse Technology logo

ProFuse Technology Secures $1.5M Pre

Recently funded · $1.5M Pre-seedHospitals and Health CareILView source

Get the full ProFuse Technology company profile

Access contacts, investors, buying signals & more

Open in Dashboard

ProFuse Technology, a biotechnology company focused on developing muscle therapeutics, has closed a $1.5M pre-seed funding round. The capital is slated to advance selected hits into lead optimization, leveraging the company's proprietary high-throughput human skeletal muscle platform.

Building on scientific breakthroughs from the Weizmann Institute of Science, ProFuse aims to discover first-in-class solutions for sarcopenia and GLP-1-induced muscle loss. Its platform enables predictive, high-throughput screening in physiologically relevant human muscle systems, a significant advancement over traditional models.

Other Israel companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Pre-seed rounds

Companies that recently closed a Pre-seed round.

#CompanyAmount
1
Alchemic (previously Echo) logo

Alchemic (previously Echo)

India

$300.0K
2
Stoa Group logo

Stoa Group

United States

$2.4M
3
Surtr Defense Systems (YC P26) logo

Surtr Defense Systems (YC P26)

$4.8M
4
Tell Me logo

Tell Me

Turkey

$152.0K
5
NanoInGreen logo

NanoInGreen

$16.0K